vs
AtriCure, Inc.（ATRC）与WSFS FINANCIAL CORP（WSFS）财务数据对比。点击上方公司名可切换其他公司
WSFS FINANCIAL CORP的季度营收约是AtriCure, Inc.的2.0倍（$275.3M vs $140.5M），AtriCure, Inc.同比增速更快（13.1% vs 7.5%），过去两年AtriCure, Inc.的营收复合增速更高（13.6% vs 1.7%）
AtriCure是一家专注于心房颤动及相关心脏病症治疗的医疗设备企业，研发并生产创新外科手术工具与疗法，主要服务北美、欧洲、亚太地区的医院、心脏外科中心及医疗机构，为微创心脏手术提供高效可靠的适配解决方案。
WSFS金融集团是一家金融服务企业，核心子公司WSFS银行是总部位于特拉华州及大特拉华谷地区规模最大、经营历史最久的本地管理银行与财富管理机构。集团共运营115个网点，其中88个为银行网点，分布在宾夕法尼亚、特拉华、新泽西、佛罗里达、弗吉尼亚、内华达六州，提供全面金融服务。
ATRC vs WSFS — 直观对比
营收规模更大
WSFS
是对方的2.0倍
$140.5M
营收增速更快
ATRC
高出5.6%
7.5%
两年增速更快
ATRC
近两年复合增速
1.7%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $140.5M | $275.3M |
| 净利润 | — | $86.8M |
| 毛利率 | 75.0% | — |
| 营业利润率 | 1.8% | — |
| 净利率 | — | 31.5% |
| 营收同比 | 13.1% | 7.5% |
| 净利润同比 | — | 31.7% |
| 每股收益（稀释后） | $0.04 | $1.64 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRCWSFS
| Q1 26 | — | $275.3M | ||
| Q4 25 | $140.5M | $271.9M | ||
| Q3 25 | $134.3M | $270.5M | ||
| Q2 25 | $136.1M | $267.5M | ||
| Q1 25 | $123.6M | $256.1M | ||
| Q4 24 | $124.3M | $261.5M | ||
| Q3 24 | $115.9M | $267.7M | ||
| Q2 24 | $116.3M | $266.0M |
净利润ATRCWSFS
| Q1 26 | — | $86.8M | ||
| Q4 25 | — | $72.7M | ||
| Q3 25 | $-267.0K | $76.4M | ||
| Q2 25 | $-6.2M | $72.3M | ||
| Q1 25 | $-6.7M | $65.9M | ||
| Q4 24 | — | $64.2M | ||
| Q3 24 | $-7.9M | $64.4M | ||
| Q2 24 | $-8.0M | $69.3M |
毛利率ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | 75.0% | — | ||
| Q3 25 | 75.5% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 74.9% | — | ||
| Q4 24 | 74.5% | — | ||
| Q3 24 | 74.9% | — | ||
| Q2 24 | 74.7% | — |
营业利润率ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | 1.8% | 35.8% | ||
| Q3 25 | 0.2% | 37.3% | ||
| Q2 25 | -4.5% | 35.7% | ||
| Q1 25 | -4.8% | 34.0% | ||
| Q4 24 | -11.7% | 32.3% | ||
| Q3 24 | -6.4% | 31.9% | ||
| Q2 24 | -6.2% | 34.0% |
净利率ATRCWSFS
| Q1 26 | — | 31.5% | ||
| Q4 25 | — | 26.7% | ||
| Q3 25 | -0.2% | 28.3% | ||
| Q2 25 | -4.5% | 27.0% | ||
| Q1 25 | -5.5% | 25.7% | ||
| Q4 24 | — | 24.6% | ||
| Q3 24 | -6.8% | 24.1% | ||
| Q2 24 | -6.9% | 26.0% |
每股收益（稀释后）ATRCWSFS
| Q1 26 | — | $1.64 | ||
| Q4 25 | $0.04 | $1.33 | ||
| Q3 25 | $-0.01 | $1.37 | ||
| Q2 25 | $-0.13 | $1.27 | ||
| Q1 25 | $-0.14 | $1.12 | ||
| Q4 24 | $-0.33 | $1.08 | ||
| Q3 24 | $-0.17 | $1.08 | ||
| Q2 24 | $-0.17 | $1.16 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $167.4M | — |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $491.9M | $2.7B |
| 总资产 | $654.2M | $22.1B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | $167.4M | $1.7B | ||
| Q3 25 | $147.9M | — | ||
| Q2 25 | $117.8M | — | ||
| Q1 25 | $99.9M | — | ||
| Q4 24 | $122.7M | $1.2B | ||
| Q3 24 | $130.3M | — | ||
| Q2 24 | $114.0M | — |
总债务ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | $61.9M | — | ||
| Q2 25 | $61.9M | — | ||
| Q1 25 | $61.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $61.9M | — | ||
| Q2 24 | $61.9M | — |
股东权益ATRCWSFS
| Q1 26 | — | $2.7B | ||
| Q4 25 | $491.9M | $2.7B | ||
| Q3 25 | $476.5M | $2.8B | ||
| Q2 25 | $464.5M | $2.7B | ||
| Q1 25 | $454.6M | $2.7B | ||
| Q4 24 | $461.0M | $2.6B | ||
| Q3 24 | $465.0M | $2.7B | ||
| Q2 24 | $462.1M | $2.5B |
总资产ATRCWSFS
| Q1 26 | — | $22.1B | ||
| Q4 25 | $654.2M | $21.3B | ||
| Q3 25 | $635.4M | $20.8B | ||
| Q2 25 | $608.8M | $20.8B | ||
| Q1 25 | $591.6M | $20.5B | ||
| Q4 24 | $609.3M | $20.8B | ||
| Q3 24 | $615.1M | $20.9B | ||
| Q2 24 | $597.3M | $20.7B |
负债/权益比ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | 0.13× | — | ||
| Q2 25 | 0.13× | — | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.13× | — | ||
| Q2 24 | 0.13× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $20.0M | — |
| 自由现金流经营现金流 - 资本支出 | $18.4M | — |
| 自由现金流率自由现金流/营收 | 13.1% | — |
| 资本支出强度资本支出/营收 | 1.1% | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $48.3M | — |
8季度趋势，按日历期对齐
经营现金流ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | $20.0M | $220.0M | ||
| Q3 25 | $26.7M | $121.5M | ||
| Q2 25 | $21.6M | $37.2M | ||
| Q1 25 | $-11.0M | $8.7M | ||
| Q4 24 | $5.8M | $219.9M | ||
| Q3 24 | $20.0M | $3.1M | ||
| Q2 24 | $7.4M | $44.8M |
自由现金流ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | $18.4M | $213.6M | ||
| Q3 25 | $24.1M | $120.3M | ||
| Q2 25 | $19.0M | $35.2M | ||
| Q1 25 | $-13.2M | $6.3M | ||
| Q4 24 | $3.1M | $205.6M | ||
| Q3 24 | $16.4M | $-489.0K | ||
| Q2 24 | $5.0M | $42.1M |
自由现金流率ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | 13.1% | 78.6% | ||
| Q3 25 | 18.0% | 44.5% | ||
| Q2 25 | 13.9% | 13.2% | ||
| Q1 25 | -10.7% | 2.5% | ||
| Q4 24 | 2.5% | 78.6% | ||
| Q3 24 | 14.1% | -0.2% | ||
| Q2 24 | 4.3% | 15.8% |
资本支出强度ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | 1.1% | 2.3% | ||
| Q3 25 | 1.9% | 0.5% | ||
| Q2 25 | 2.0% | 0.7% | ||
| Q1 25 | 1.8% | 0.9% | ||
| Q4 24 | 2.2% | 5.5% | ||
| Q3 24 | 3.1% | 1.4% | ||
| Q2 24 | 2.1% | 1.0% |
现金转化率ATRCWSFS
| Q1 26 | — | — | ||
| Q4 25 | — | 3.03× | ||
| Q3 25 | — | 1.59× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | 0.13× | ||
| Q4 24 | — | 3.43× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.65× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATRC
| Appendage Management | $45.5M | 32% |
| Openheart | $38.5M | 27% |
| Other | $26.2M | 19% |
| Pain Management | $22.6M | 16% |
| Minimally Invasive | $7.7M | 6% |
WSFS
暂无分部数据
